INTRODUCTION
Ischemic heart disease and stroke and other forms of cerebrovascular disease are leading causes of death globally 1 . Hypercholesterolemia, an important risk factor for these diseases, is closely related to dietary habits. Therefore, functionality of foods attracts attention for the prevention and improvement of symptoms. Mushrooms have long been considered to have beneficial physiological effects. Their cholesterol-lowering 2 4 and antiatherogenic 5 effects are known. The hypocholesterolemic compound, eritadenine is isolated from Lentinus edodes and to a lesser extent in Agaricus bisporus 6 9 .
We previously evaluated functionality of foods using comprehensive analyses of genomes 10 12 and demonstrat-frondosa powder using DNA microarrays. In addition, the mechanism by which G. frondosa improves lipid metabolism was examined.
MATERIALS AND METHODS

Experimental samples
G. frondosa strain: Gf433 were cultured according to Yoneyama et al. 13 . Harvested fruit bodies were autoclaved at 100 for 10 min, freeze-dried, and powdered.
Animals and diets
The experimental diet was prepared according to the AIN-76 formulation. Dietary fiber content in mushrooms was calculated according to food composition data 14 . Cellulose powder in the control diet was substituted with mushroom powder in the experimental diet, and the sucrose content was modified Table 1 . Four-week-old male ICR mice CLEA Japan Inc., Tokyo were fed AIN-76 pellets for 1 week of adaptation. The mice were then randomly divided into three groups of five each and fed the normal diet N group; AIN-76 pellets or experimental diets containing 1 cholesterol HC group or 1 cholesterol and G. frondosa powder HC G group for 4 weeks Table 1 . The mice were kept in an air-conditioned room at 23 2 with 40 10 relative humidity, a 12-h light/dark cycle was followed, and free access to food and water was allowed. The mice were fasted for 16 h before being anesthetized with diethyl ether. Blood was immediately collected from hearts. Livers were isolated and stored at 80 in RNAlater ® Ambion, Austin, TX, USA until RNA extraction. All mice were treated according to the guidelines for experimental animal use of Obihiro University of Agriculture and Veterinary Medicine, Japan.
Analysis of plasma and liver lipids
Blood was separated into plasma by centrifugation 4 , 1500 g, 15 min . Plasma total cholesterol TC , high-density lipoprotein cholesterol HDL-C , triglyceride TG , and phospholipid PL concentrations were measured using commercial enzymatic test kits 10 . LDL cholesterol LDL-C was estimated as the difference between TC and HDL-C concentrations. Liver lipids were extracted according to Danno et al. 15 . TC, TGs, and PLs in the extracts were measured using the kits. Statistical analyses were performed using ANOVA with the Tukey-Kramer HSD test p 0.05 with JMP 5.0.1 J SAS Institute, Cary, NC, USA .
DNA microarray analysis
Total RNA was isolated from the livers using an SV total RNA Isolation System Promega, Madison, WI, USA . Its quality was examined by its absorbance and by electrophoresis. Equal amounts of the RNA from five mice of each experiment group were pooled to normalize individual differences for DNA microarray analysis.
Labeled cRNA was synthesized using 2 μg of total RNA as a template with GeneChip ® One-Cycle Target Labeling The probes with the data flag presence were extracted. In comparison with the probes for the N group, the extracted probes whose signal level changed 1.5-fold were identified. Functional clustering of differentially expressed genes was assigned according to the Database for Annotation, Visualization and Integrated Discovery DAVID v6.7 http://david.abcc.ncifcrf.gov/ at medium stringency based on the Gene Ontology GO biological process. These genes were categorized and mapped onto pathways using the Kyoto Encyclopedia of Genes and Genomes KEGG pathway database http://www.kegg.jp/ja/ . Table 2 and 3, respectively. Total lipids, TC, and TG contents in livers of the HC group increased considerably compared with those of the N group Table 2 . TC/PL and LDL-C/PL in plasma significantly increased and TG/PL slightly decreased in the HC group Table 3 . Hepatic TC and TG contents were lower in the HC G group than in the HC group. In the HC G group, TC/PL in plasma were significantly lower than those in the HC group but similar to those in the N group. LDL-C/PL in the HC G group were also lower than those in the HC group. TG/PL in the HC G group was significantly lower than those in the N group. It has been reported that the serum TC/PL is significantly increased in the coronary heart disease group in contrast to the normal group 16 . Our data suggest that ingestion of G. frondosa reduced this ratio. 3.2 Altered expression of hepatic genes following cholesterol and G. frondosa supplementation To characterize the mechanisms leading to differences in liver and plasma cholesterol and TG contents between the experimental diet groups, hepatic gene expression was analyzed using DNA microarray. Table 4 shows significantly altered p 0.05 GO terms related to lipid metabolism. In lipid metabolic processes, steroid metabolic processes, and regulation of lipid metabolic processes, no differences were observed between the number of genes with altered expression in the experimental diet groups. Table 5 shows the expression levels of genes belonging to the GO term involved in cholesterol metabolism Table  4 . The expression levels in the HC group were compared with those in the N group.
Effects of 1 cholesterol intake on the expression of lipid metabolism-related genes
In GO:0042632, cholesterol homeostasis, Abcg5 ATPbinding cassette, sub-family G, member 5 expression was Table 5 Change (vs N group) in expression of hepatic genes involved in cholesterol homeostasis, cholesterol metabolic process, and regulation of lipid metabolic process.
and induces ABCG5/ABCG8 upregulation by activating the liver X receptor LXR 20 . Thus, it is expected that the system for cholesterol excretion from the liver to the bile is upregulated in the cholesterol-supplemented mice. In contrast, the gene encoding Apolipoprotein B Apob , the primary apolipoprotein responsible for endogenous lipoprotein metabolism in VLDLs, was unexpectedly downregulated 0.38-fold in the HC group. These results indicate that VLDL excretion from the liver was lowered in these animals. Interestingly, plasma Fabp4 adipocyte FA-binding protein 4 , was reportedly increased in metabolic syndrome patients 21 and upregulated 4.16-fold. TG content in the livers of the HC group was higher than that of the N group Table 2 , and Fabp4 expression was positively correlated with liver fat content in humans 22 . Moreover, Fu et al. showed that Fabp4 overexpression in human THP-1 monocytic cells accelerates cholesterol and TG accumulation in macrophage foam cells 23 .
In GO:0008203 cholesterol metabolic process, Hmgcs1, Hmgcs2, Idi1, Cyp51, Tm7sf2, Hsd17b7, and Dhcr24 were downregulated Fig. 1 . Increases in dietary cholesterol are likely to suppress de novo cholesterol synthesis, leading to suppression of these genes. It was expected that dietary cholesterol would promote primary bile acid biosynthesis in the liver as cholesterol catabolism was increased. However, Cyp39a1 and Cyp46a1 of the 24-hydroxylase pathway were not upregulated. In addition, upregulation of cholesterol 7a-hydroxylase Cyp7a1 , which performs the rate-limiting step of bile acid biosynthesis and is controlled by LXRα, was not observed data not shown . These results show that increased liver cholesterol does not necessarily upregulate genes involved in bile acid biosynthesis.
Srebf1, which encodes sterol regulatory element binding factor 1 SREBP1 , was upregulated 3.15-fold in cholesterol-fed mice 25 . In contrast, expression of Scarb1, which encodes the HDL receptor, was not upregulated 1.16-fold . Cai et al. reported that SAA, which is a ligand for the scavenger receptor class B type I SR-B1 , inhibits HDL binding and selective cholesterol ester CE uptake and thereby influences HDL-C metabolism 26 . In agreement, Saa1 was increased 2.09-fold in the HC group. In the liver, SR-B1 plays a key role in the clearance of HDL CE and facilitates cholesterol transport from the periphery to the liver 26 . Therefore, it is supposed that reverse cholesterol transport through SR-B1 was inhibited by increased SAA production. Angiopoietin-like 4 Angptl4 is a known inhibitor of lipoprotein lipase LPL activity. In this study, Angptl4 expression was decreased 0.50-and 0.57-fold . When LPL-dependent VLDL lipolysis is inhibited, plasma TG concentrations rise. Therefore, Angptl4 downregulation may have contributed to decreased plasma TG concentrations in the HC group. Lichtenstein et al. also suggested that Angptl4 induced cholesterol synthesis in the liver is secondary to inhibition of LPL-and hepatic lipase-dependent hepatic cholesterol uptake 27 . Although hepatic and plasma cholesterol concentrations were increased by dietary cholesterol Table 2 and 3 , suppression of cholesterol synthesis in the liver may be related to Angptl4 downregulation. Tomita reported that Angptl4 suppression is involved in the pathology of non-alcoholic steatohepatitis NASH 28 . Thus, this observation may indicate NASH development in the HC group. Caveolin, caveolae protein 1 Cav1 , which encodes a cholesterol-binding protein and plays an important role in intracellular cholesterol transport, was upregulated 1.54-fold. Removal of this protein is essential for activation of endothelial nitric oxide synthase eNOS , which is an important antiarteriosclerotic mechanism. Feron et al. demonstrated that high caveolin-1 expression decreased eNOS activation 29 . In addition, increased LDL-C significantly upregulates caveolin expression. Consistent with this, LDL-C was increased in the HC group Table 3 and may have led to slight Cav1 upregulation.
3.4 Effect of G. frondosa intake on the expression of lipid metabolism genes in cholesterol-loaded mice livers There were differences in the expression of lipid metabolic processes GO:0006629 Cyp46a1 were not upregulated in the HC G group as well as in the HC group. Substantial differences in the expression of the genes of de novo cholesterol synthesis and LDL receptors were not found between the HC G and HC groups. Although there were no significant differences in liver cholesterol, enhanced cholesterol excretion led to significant decrease in plasma cholesterol in the HC G group compared with the HC group. Moreover, Apob expression in the HC G group was similar to that in the N group. Srebf1 expression is associated with fatty liver and hyperlipidemia. In these experiments, Srebf1 expression was elevated in both cholesterol-fed mice groups, but it was lower in the HC G group 2.74-fold than in the HC group 3.15-fold . These results suggest decreasing hepatic TG content in the HC G group. Moreover, Fabp4 expression was decreased to the level in the N group in the G. frondosa-supplemented mice, and Cav1 was upregulated in the HC group but not in the HC G group. Hence, caveolinmediated eNOS inhibition may have been limited in the HC G group. G. frondosa intake promoted cholesterol metabolism in a previous study 4 . However, similar to a study using rats by Fukushima et al. 2 , upregulation of bile acid metabolism was not observed in this study. The cholesterol-lowering effects of these mushrooms are thought to be caused by increased excretion of cholesterol and bile acid in feces 2, 4 , which may involve mushroom dietary fiber as discussed. G. frondosa contains soluble 0.3 g/100 g boiled mushroom and insoluble 2.4 g/100 g boiled mushroom fibers 14 . These dietary fibers were corrected using insoluble cellulose powder so that the fiber content was the same in all groups. 2 , but the mechanism of this effect was unclear. Kubo and Nanba also showed that cholesterol and bile acid in feces of rats with 1 cholesterol 10 lard and 2 corn oil were increased by G. frondosa intake 4 . As mentioned above, although a significant increase in Cyp7a1 expression was not observed, genes related to cholesterol transport and excretion into bile were slightly upregulated in the HC G group. Hence, these minor transcriptional changes may have cumulatively influenced plasma cholesterol content.
3.5 Effects of cholesterol and G. frondosa intake on the expression of other genes As shown in Table 5 , the leptin receptor gene Lepr was upregulated in the HC G group 1.62-fold . Therefore, we focused on the gene expression of adipocytokine signaling components Fig. 2 . As for 5 -AMP-activated protein kinase, which controls sugar and lipid metabolism and plays an important role in energy metabolism, Ca 2 -calmodulin-dependent protein kinase kinase 1 Camkk1 was upregulated 2.27-fold in the HC G group. Downstream, carnitine palmitoyltransferase Cpt1a , which is a key enzyme for β-oxidation of long-chain FAs in liver mitochondria 31 , was up-regulated 3.02-fold. This may have promoted FA oxidation, which led to decrease in liver and plasma TG. Cpt1a levels in the experimental diet groups were significantly higher than those in the N group, and the level in the HC G group was highest among the three groups. Hence, Cpt1a upregulation may moderate hepatic TG accumulation by excess cholesterol intake. This result indicates the presence of compounds in G. frondosa that induce Cpt1a upregulation. Because the mRNA level does not necessarily accord with enzyme activity, metabolic changes are merely inferred from analyses of mRNA expression. Nonetheless, these data offer an explanation for the decline in hepatic and plasma TG concentrations in the HC G group compared with the HC group. Thus, β-oxidation was promoted via adipocytokine signaling following supplementation with G. frondosa, and the related genes Lepr, Camkk1, Prkag2, Cpt1a were elevated in the HC G group compared with the HC group. Hence, dietary intake of G. frondosa during high cholesterol feeding is expected to promote fat catabolism. As suggested above, SAA inhibits cellular hepatic cholesterol reverse transport. Accordingly, Saa1 was downregulated 1.40-fold and Scarb1 was upregulated 1.53-fold in the HC G group compared with the HC group Table 5 , suggesting that cholesterol reverse transport was promoted by dietary G. frondosa. A previous study indicates that elevated SAA expression is associated with cardiovascular risks, including obesity, insulin resistance, metabolic syndrome, and diabetes 32 . In this study, expression of SAAs Saa1, Saa2, Saa3, and Saa4 was significantly upregulated in the HC group compared with the N group 1.54-to 3.56-fold , but it was suppressed in the HC G group 1.19-to 1.54-fold . These data suggest that dietary intake of G. frondosa suppresses the expression of SAAs that induce arteriosclerosis.
These data indicate that dietary G. frondosa during cholesterol feeding promotes fat catabolism by inducing adipocytokine signaling and β-oxidation, and subsequently leads to antiatherogenic effects. Hence, dietary G. frondosa can prevent and improve the symptoms of obesity, diabetes, and arteriosclerosis induced by hypercholesterolemia.
